Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - US-China Biomedical Technology, Inc. | uschina_10q-083118.htm |
| EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - US-China Biomedical Technology, Inc. | uschina_10q-ex3101.htm |
| EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - US-China Biomedical Technology, Inc. | uschina_10q-ex3102.htm |
| EX-32.1 - CERTIFICATION - US-China Biomedical Technology, Inc. | uschina_10q-ex3201.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of US-China Biomedical Technology, Inc., a Nevada corporation, (the “Company”) on Form 10-Q for the period ending August 31, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Qingxi Huang, Chief Financial Officer of the Company, certify the following pursuant to Section 18, U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: October 16, 2018 | By: | /s/ Qingxi Huang | |
| Qingxi Huang | |||
| Chief Financial Officer (Principal Accounting Officer) |